Subbu Nambi
Stock Analyst at Guggenheim
(1.74)
# 2,061
Out of 4,414 analysts
10
Total ratings
33.33%
Success rate
-3.48%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Reiterates: Neutral | n/a | $18.58 | - | 2 | Apr 5, 2024 | |
| CSTL Castle Biosciences | Initiates: Buy | $25 | $22.84 | +9.46% | 1 | Dec 14, 2023 | |
| MYGN Myriad Genetics | Initiates: Buy | $23 | $19.22 | +19.67% | 1 | Dec 14, 2023 | |
| NTRA Natera | Initiates: Buy | $70 | $93.72 | -25.31% | 1 | Dec 14, 2023 | |
| EXAS Exact Sciences | Initiates: Buy | $90 | $60.54 | +48.66% | 1 | Dec 14, 2023 | |
| PACB Pacific Biosciences of California | Initiates: Neutral | n/a | $1.76 | - | 1 | Dec 14, 2023 | |
| ILMN Illumina | Initiates: Buy | $155 | $123.99 | +25.01% | 1 | Dec 14, 2023 | |
| AKYA Akoya Biosciences | Initiates: Neutral | n/a | $3.99 | - | 1 | Dec 14, 2023 | |
| TXG 10x Genomics | Initiates: Buy | $60 | $26.29 | +128.22% | 1 | Dec 14, 2023 |
Guardant Health
Apr 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $18.58
Upside: -
Castle Biosciences
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $22.84
Upside: +9.46%
Myriad Genetics
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $19.22
Upside: +19.67%
Natera
Dec 14, 2023
Initiates: Buy
Price Target: $70
Current: $93.72
Upside: -25.31%
Exact Sciences
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $60.54
Upside: +48.66%
Pacific Biosciences of California
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.76
Upside: -
Illumina
Dec 14, 2023
Initiates: Buy
Price Target: $155
Current: $123.99
Upside: +25.01%
Akoya Biosciences
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $3.99
Upside: -
10x Genomics
Dec 14, 2023
Initiates: Buy
Price Target: $60
Current: $26.29
Upside: +128.22%